Heidi A. Waldorf BA, MD

Heidi A Waldorf, MD is a nationally and internationally respected expert and sought after lecturer in the field of Dermatology and Cosmetic Medicine, including skin rejuvenation, soft tissue augmentation, cosmetic use of botulinum toxin, noninvasive fat reduction, laser and other energy based device technology and cosmeceuticals., Dr. Waldorf completed her undergraduate and medical education and training at Harvard University and the University of Pennsylvania, after which she completed a fellowship in Mohs Micrographic Surgery, Laser Surgery and Cosmetic Dermatologic Surgery.
Dr. Waldorf serves as an investigator, speaker, consultant, advisory board member and trainer for major industry producers of drugs, devices and cosmeceuticals, allowing her to participate in the development of treatment protocols and to offer her patients the latest therapies. She is currently a principle investigator for Revance Therapeutics’ new botulinum toxin, and was a lead investigator for the FDA trial of Kythera’s fat-dissolving injectable, Kybella, approved in 2015 to reduce submental fullness.